Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lomon

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Clinical Therapeutics|August 25, 2014
Vitamin K antagonist treatment in patients with atrial fibrillation and time in therapeutic range in four European countriesFrançois-Emery Cotté, Hicham Benhaddi, Isabelle Duprat-Lomon, et al.
Plos One|June 11, 2014
Effects of novel isoform-selective phosphoinositide 3-kinase inhibitors on natural killer cell functionSung Su Yea, Lomon So, Sharmila Mallya, et al.
Adolescence|January 24, 2007
Bullying in elementary school, high school, and collegeMark S Chapell, Stefanie L Hasselman, Theresa Kitchin, et al.
Pharmacoeconomics|August 11, 2006
A comparative review of health-related quality-of-life measures for use in HIV/AIDS clinical trialsDarren J Clayson, Diane J Wild, Paul Quarterman, et al.
Plos One|March 4, 2014
Resistance to mTOR kinase inhibitors in lymphoma cells lacking 4EBP1Sharmila Mallya, Briana A Fitch, J Scott Lee, et al.
The European Respiratory Journal|February 7, 2003
Effectiveness of oral moxifloxacin in standard first-line therapy in community-acquired pneumoniaA Torres, J F Muir, P Corris, et al.
RSC Advances|October 24, 2022
Enhancement of V<sub>2</sub>O<sub>5</sub> Li-ion cathode stability by Ni/Co doped Li-borate-based glassSumeth Siriroj, Jintara Padchasri, Amorntep Montreeuppathum, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 12, 2014
mTOR kinase inhibitors promote antibody class switching via mTORC2 inhibitionJose J Limon, Lomon So, Stefan Jellbauer, et al.
Chest|August 9, 2003
An economic evaluation of sequential i.v./po moxifloxacin therapy compared to i.v./po co-amoxiclav with or without clarithromycin in the treatment of community-acquired pneumoniaMichael F Drummond, Debbie L Becker, Margaret Hux, et al.
Respiratory Medicine|February 28, 2002
Quality of life in acute exacerbation of chronic bronchitis: results from a German population studyH Doll, P Grey-Amante, I Duprat-Lomon, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Clinical Therapeutics|August 25, 2014
Vitamin K antagonist treatment in patients with atrial fibrillation and time in therapeutic range in four European countriesFrançois-Emery Cotté, Hicham Benhaddi, Isabelle Duprat-Lomon, et al.
Plos One|June 11, 2014
Effects of novel isoform-selective phosphoinositide 3-kinase inhibitors on natural killer cell functionSung Su Yea, Lomon So, Sharmila Mallya, et al.
Adolescence|January 24, 2007
Bullying in elementary school, high school, and collegeMark S Chapell, Stefanie L Hasselman, Theresa Kitchin, et al.
Pharmacoeconomics|August 11, 2006
A comparative review of health-related quality-of-life measures for use in HIV/AIDS clinical trialsDarren J Clayson, Diane J Wild, Paul Quarterman, et al.
Plos One|March 4, 2014
Resistance to mTOR kinase inhibitors in lymphoma cells lacking 4EBP1Sharmila Mallya, Briana A Fitch, J Scott Lee, et al.
The European Respiratory Journal|February 7, 2003
Effectiveness of oral moxifloxacin in standard first-line therapy in community-acquired pneumoniaA Torres, J F Muir, P Corris, et al.
RSC Advances|October 24, 2022
Enhancement of V<sub>2</sub>O<sub>5</sub> Li-ion cathode stability by Ni/Co doped Li-borate-based glassSumeth Siriroj, Jintara Padchasri, Amorntep Montreeuppathum, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 12, 2014
mTOR kinase inhibitors promote antibody class switching via mTORC2 inhibitionJose J Limon, Lomon So, Stefan Jellbauer, et al.
Chest|August 9, 2003
An economic evaluation of sequential i.v./po moxifloxacin therapy compared to i.v./po co-amoxiclav with or without clarithromycin in the treatment of community-acquired pneumoniaMichael F Drummond, Debbie L Becker, Margaret Hux, et al.
Respiratory Medicine|February 28, 2002
Quality of life in acute exacerbation of chronic bronchitis: results from a German population studyH Doll, P Grey-Amante, I Duprat-Lomon, et al.
Pageof 5